Fortress Biotech, Inc.

General ticker "FBIO" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $80.6M (TTM average)

Fortress Biotech, Inc. follows the US Stock Market performance with the rate: 17.4%.

Estimated limits based on current volatility of 4.8%: low 3.39$, high 3.73$

Factors to consider:

  • Total employees count: 78 (-22.8%) as of 2025
  • Top business risk factors: Clinical trial failure, Regulatory and compliance, Market competition, Inability to raise capital, Profitability
  • Price in estimated range
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [2.48$, 5.70$]
  • 2026-12-31 to 2027-12-31 estimated range: [2.18$, 5.08$]

Financial Metrics affecting the FBIO estimates:

  • Positive: with PPE of -2.2 at the end of fiscal year the price was neutral
  • Negative: negative Operating cash flow
  • Negative: negative Operating income
  • Positive: Investing cash flow per share per price, % of 10.15 > -0.60
  • Positive: 19.19 < Shareholder equity ratio, % of 26.88 <= 42.57
  • Positive: Inventory ratio change, % of -6.81 <= -0.75

Similar symbols

Short-term FBIO quotes

Long-term FBIO plot with estimates

Financial data

YTD 2024-12-31 2025-12-31
Operating Revenue $57.67MM $63.26MM
Operating Expenses $168.05MM $133.48MM
Operating Income $-110.38MM $-70.22MM
Non-Operating Income $-10.16MM $36.69MM
Interest Expense $9.93MM $10.11MM
R&D Expense $56.88MM $11.90MM
Income(Loss) $-120.54MM $-33.53MM
Taxes $0.31MM $-0.62MM
Net Income(Loss)* $-46.00MM $6.82MM
Stockholders Equity $22.74MM $49.87MM
Inventory $14.43MM $9.62MM
Assets $144.22MM $185.55MM
Operating Cash Flow $-80.19MM $-65.78MM
Capital expenditure $15.00MM $0.00MM
Investing Cash Flow $-15.00MM $10.12MM
Financing Cash Flow $70.64MM $77.44MM
Earnings Per Share** $-2.21 $0.24

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.